Management of Mixed Mechanism Glaucoma Secondary to NewColorIris Implant Using an Ab Externo Xen Gel Stent

Background and Aims We present a case of mixed mechanism glaucoma following NewColorIris implant that was successfully treated using an off‐label use of Xen Gel Stent. Methods A retrospective review of the patient′s medical records was conducted following the acquisition of informed consent. Results A 42‐year‐old female with a history of bilateral cosmetic iris implants presented to the emergency room due to corneal decompensation and a secondary mixed mechanism glaucoma caused by implant iris chafing in her left eye. The patient underwent prosthetic iris implant removal and had persistently elevated intraocular pressures (IOPs) postoperatively. She underwent a subsequent off‐label Xen Gel Stent implantation which has successfully controlled her eye pressures without the need for supplementary antiglaucoma medications for 13 months. This off‐label use of the Xen Gel Stent helped the patient maintain excellent IOP and satisfied the patient′s cosmetic preferences. Conclusion Xen Gel Stent may be a safe and effective option to treat secondary glaucoma due to cosmetic iris implants.